Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL)

von: Chiara Napoletano

2020, in: Cancers

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis

von: Fabio Scirocchi

2022, in: International Journal of Molecular Sciences

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets

von: Chiara Napoletano

2019, in: Journal of Clinical Medicine

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity

von: Fulvia Ceccarelli

2023, in: Journal of Immunology Research

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response

von: Fabio Scirocchi

2022, in: EBioMedicine

Circulating CD137

2023, in: International Journal of Molecular Sciences

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib

von: Fabio Scirocchi

2021, in: Frontiers in Oncology

Immune Effects of Trastuzumab

von: Marianna Nuti, Filippo Bellati, Valeria Visconti, Chiara Napoletano, Lavinia Domenici, Jlenia Caccetta, Ilaria Grazia Zizzari, Ilary Ruscito, Hassan Rahimi, Pierluigi Benedetti-Panici, Aurelia Rughetti

2011, in: Journal of Cancer

Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures.

von: Alice Fraveto

2015, in: PLoS ONE

Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View

von: Filippo Bellati

2011, in: Clinical and Developmental Immunology

CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line

von: Alain Gelibter

2024, in: Journal of Translational Medicine

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma

von: Ilaria Grazia Zizzari

2020, in: Cancers

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients

von: Ilaria Grazia Zizzari

2020, in: Journal of Personalized Medicine

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.

von: Ilaria Grazia Zizzari

2015, in: PLoS ONE

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma

von: Angelica Pace

2022, in: International Journal of Molecular Sciences

TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.

von: Anna Maria Lustri

2017, in: PLoS ONE

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs

von: Angelica Pace

2023, in: Journal of Translational Medicine

Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite Anisakis pegreffii (Nematoda: Anisakidae)

von: Marialetizia Palomba

2023, in: Frontiers in Cellular and Infection Microbiology

Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells

von: Sabina Di Matteo

2021, in: Scientific Reports

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells

von: Federico Battisti

2017, in: Frontiers in Immunology